Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma

Publication date: Available online 30 May 2020Source: Pharmacological ResearchAuthor(s): Pedro Miguel Lacal, Maria Grazia Atzori, Federica Ruffini, Manuel Scimeca, Elena Bonanno, Rosella Cicconi, Maurizio Mattei, Roberta Bernardini, Stefania D’Atri, Lucio Tentori, Grazia Graziani
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research